GlassScriptPhysician profile
Simrita Sidhu
NPI 1619938834
$937.25
in general payments reported to CMS, 2019-2025
10 companies · $83.16 in 2025
The $83.16 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $314 · 2020: $136 · 2021: $154 · 2022: $29.84 · 2023: $105 · 2024: $116 · 2025: $83.16.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $304.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $303.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $378.68 | 2019-2024 | Trelegy Ellipta |
| Astrazeneca Pharmaceuticals LP | $205.06 | 2020-2025 | Airsupra, Farxiga |
| Pfizer INC. | $93.58 | 2019-2024 | |
| Janssen Pharmaceuticals, INC | $80.83 | 2019 | |
| Amarin Pharma, INC. | $62.25 | 2019-2021 | |
| Lilly USA, LLC | $35.67 | 2024 | Mounjaro, Zepbound |
| Astellas Pharma US INC | $30.84 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $19.93 | 2023 | |
| Cook Medical LLC | $16.59 | 2022 | |
| Amgen INC. | $13.82 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Simrita Sidhu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.